Insider Buying: GFG Resources Inc (CVE:GFG) Senior Officer Buys 115,384 Shares of Stock

GFG Resources Inc (CVE:GFG - Get Free Report) Senior Officer Anders Carlson bought 115,384 shares of the firm's stock in a transaction that occurred on Monday, September 23rd. The shares were purchased at an average cost of C$0.13 per share, for a total transaction of C$14,999.92.

Anders Carlson also recently made the following trade(s):

• On Monday, September 16th, Anders Carlson purchased 90,000 shares of GFG Resources stock. The stock was purchased at an average cost of C$0.13 per share, with a total value of C$11,700.00.

GFG Resources Stock Down 3.8 %

GFG opened at C$0.13 on Wednesday. The company has a fifty day moving average price of C$0.10 and a 200-day moving average price of C$0.09. The firm has a market capitalization of C$30.07 million, a P/E ratio of -2.50 and a beta of 2.21. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.66 and a quick ratio of 2.98. GFG Resources Inc has a one year low of C$0.07 and a one year high of C$0.14.

About GFG Resources

GFG Resources Inc engages in the acquisition, exploration, and development of mineral properties in Canada and the United States. The company primarily explores for gold deposits. It holds interests in the Montclerg gold project consisting of 5 patented and 110 unpatented mining claims located near the east of Timmins; the Pen gold project covers an area of approximately 475 square kilometers located near the southwest of the prolific gold district and town of Timmins; and the Dore gold project covers an area of approximately 212 square kilometers located in Ontario.

See Also

• Five stocks we like better than GFG Resources
• Why Are These Companies Considered Blue Chips?
• Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
• What is Insider Trading? What You Can Learn from Insider Trading
• Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
• Earnings Per Share Calculator: How to Calculate EPS
• Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

More From MarketBeat

War on Elon Escalates…

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...

Porter & Company | Sponsored

7 Chip Stocks Leading the AI Revolution

Artificial intelligence (AI) has been around for longer than many investors may think. However, the launch of ...

MarketBeat

The Great AI Election of 2024

Former House Speaker Nancy Pelosi made 20 times her salary trading Nvidia (NVDA) stock. A recent report out...

Chaikin Analytics | Sponsored

7 Low Beta Safe and Sound Stocks

If you've been investing for a significant period of time, you've probably heard a stock described as a &ldquo...

MarketBeat

Musk’s new company could top a trillion?

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...

Paradigm Press | Sponsored

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...

MarketBeat

Elon Musk’s chilling warning for humanity

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...

The Freeport Society | Sponsored

7 Stocks Under $20 You Won’t Want to Miss

The price of a stock and the value of that stock are frequently different. And many investors have learned the...

MarketBeat